This tumor-promoting effect of pathogenic TGF-β signaling could partly be manifested in an increased metastatic potential of the tumor cells, but also through paracrine angiogenic and immunosuppressive effects of TGF-β secreted by the growing tumor mass [10], [34]. Here, TGFB1 is linked to neoplasm.